EU Drugs Agency Publishes its First Report on the Medical Use of Cannabis

A new report was published this week by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) titled Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. The report addresses common questions, including: What is the evidence base for the medical use of cannabis and cannabinoids? What is the difference between cannabis preparations and medicinal products and why is this important? How is this issue regulated in the EU? The report is a response to growing interest in the topic of cannabis as more European countries develop policies and practices in this area.

The full report is available here in English.

The issue is particularly relevant for Georgia. This year, the constitutional court ruled that punishment for marijuana use is unconstitutional, but the government backed down from initial proposals to develop a legal framework for the consumption, possession, and sale of the drug, including suggestions that cultivation be legalized for export purposes, after strong backlash from the Georgian Orthodox Church and conservative political voices. 

By Samantha Guthrie

Photo: European Monitoring Centre for Drugs and Drug Addiction

Related Stories:

Parliament Adopts Amendments to Marijuana Consumption Law

Police to Start Testing Drivers for Marijuana from April

PM Says Marijuana Cultivation Bill Withdrawn from Parliament

Politician & Supporters Arrested at Cannabis Festival

Georgia’s New Gold Rush: Or the Economic Prospects of Export of Medical Marijuana

Georgian Church Objects to Cannabis Cultivation for Export

Georgian Constitutional Court Decriminalizes Marijuana Consumption